In the Media

Dr. Francis Collins, director of the NIH, highlights how MIT researchers have identified a metabolic pathway that appears to play a key role in small cell lung cancer. Collins notes that “the new findings show the promise of gene-editing technology as a research tool for uncovering elusive cancer targets.”